Literature DB >> 32931543

Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain.

Lucas Schirmer1, Chloé Hoornaert2, Debbie Le Blon3, Dimitri Eigel1, Catia Neto4, Mark Gumbleton4, Petra B Welzel1, Anne E Rosser5, Carsten Werner6, Peter Ponsaerts3, Ben Newland7.   

Abstract

Interleukin-13 (IL-13) drives cells of myeloid origin towards a more anti-inflammatory phenotype, but delivery to the brain remains problematic. Herein, we show that heparin-based cryogel microcarriers load high amounts of IL-13, releasing it slowly. Intra-striatal injection of loaded microcarriers caused local up-regulation of ARG1 in myeloid cells for pro-regenerative immunomodulation in the brain.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32931543     DOI: 10.1039/d0bm01249a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  2 in total

Review 1.  Injectable Cryogels in Biomedicine.

Authors:  Duygu Çimen; Merve Asena Özbek; Nilay Bereli; Bo Mattiasson; Adil Denizli
Journal:  Gels       Date:  2021-04-01

Review 2.  Growth Factor Therapy for Parkinson's Disease: Alternative Delivery Systems.

Authors:  Sarah Jarrin; Abrar Hakami; Ben Newland; Eilís Dowd
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.